Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Acepodia, Anheart, Applied DNA Sciences, Arch Biopartners, Aslan, Astrazeneca, Basilea, Bio-Thera Solutions, Bold, Bridge, BSP, Can-Fite, Cellink, CNS, Emergent Biosolutions, Eureka, Hao Tian Development, Humanigen, Immuneoncia, Immuron, JW Therapeutics (Shanghai), Kalytera, Kugelmeiers, Marinomed, Mateon, Moleculin, Newg Lab, Novartis, Octapharma, Ose Immunotherapeutics, Pascal, Pfizer, Pharmaceutics International, Pharmapark, Promethera, Recce, Rensselaer Polytechnic Institute, Samsung Biologics, Sterling Pharma USA, Takis, Tevogen, TLC, Tonix, Twist, Vitro Diagnostics, Zyus Life Sciences.